| 产品名称： | Streptococcus pyogenes Rosenbach |
|---|---|
| 商品货号： | TS170135 |
| Strain Designations： | Typing strain C265 F. Griffith NF14 or SFH |
| Application： | Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Lancefields group A, type 8 |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Member of pooled antigens for immunizing cattle in the production of a treatment for rheumatoid arthritis |
| Medium： | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37.0°C Atmosphere:xa0 Aerobic (5% CO2 will enhance the growth) |
| Name of Depositor： | RC Lancefield |
| Chain of Custody： | ATCC < |
| References： | Stolle RJ, Beck LR. Prevention and treatment of rheumatoid arthritis. US Patent 4,732,757 dated Mar 22 1988 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptococcus pyogenes Rosenbach |
|---|---|
| 商品货号： | TS170135 |
| Strain Designations： | Typing strain C265 F. Griffith NF14 or SFH |
| Application： | Emerging infectious disease research |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Antigenic Properties： | Lancefields group A, type 8 |
| Product Format： | freeze-dried |
| Storage Conditions： | 2°C to 8°C |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Member of pooled antigens for immunizing cattle in the production of a treatment for rheumatoid arthritis |
| Medium： | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37.0°C Atmosphere:xa0 Aerobic (5% CO2 will enhance the growth) |
| Name of Depositor： | RC Lancefield |
| Chain of Custody： | ATCC < |
| References： | Stolle RJ, Beck LR. Prevention and treatment of rheumatoid arthritis. US Patent 4,732,757 dated Mar 22 1988 |
